The pooled incidence was 14/509 (3%, 95% CI: 2–5%), as depicted in Figure 5A. Moreover, all four studies reported outcomes concerning the incidence of intracranial hemorrhage post-combined argatroban and tPA administration for patients with acute ischemic stroke. The gene discussed is PLAT; the disease is intracranial hemorrhage.